Cargando…
Conjugating Existing Clinical Drugs With Gold Nanoparticles for Better Treatment of Heart Diseases
Developing new methods to treat heart diseases is always a focus for basic research and clinical applications. Existing drugs have strong side-effects and also require lifetime administration for patients. Recent attempts of using nanoparticles (NPs) in treating atherosclerosis in animals and some h...
Autores principales: | Zhang, Jingwen, Ma, Aiqun, Shang, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987068/ https://www.ncbi.nlm.nih.gov/pubmed/29896120 http://dx.doi.org/10.3389/fphys.2018.00642 |
Ejemplares similares
-
Size dependent effects of Gold Nanoparticles in ISO-induced Hyperthyroid Rats
por: Zhang, Jingwen, et al.
Publicado: (2018) -
Animal models used in the research of nanoparticles for cardiovascular diseases
por: Dong, Caijuan, et al.
Publicado: (2021) -
Exogenous Cardiac Bridging Integrator 1 Benefits Mouse Hearts With Pre-existing Pressure Overload-Induced Heart Failure
por: Li, Jing, et al.
Publicado: (2020) -
New Supramolecular Drug Carriers: The Study of Organogel Conjugated Gold Nanoparticles
por: Kowalczuk, Joanna, et al.
Publicado: (2021) -
Gold nanoparticles: challenge of PPPM for heart failure treatment and drug delivery
por: Spivak, Mykola Ya, et al.
Publicado: (2014)